Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Swartz, R. D.
Right arrow Articles by Hartman, T. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Swartz, R. D.
Right arrow Articles by Hartman, T. L.

Journal of the American Society of Nephrology, Vol 4, 1719-1725, Copyright © 1994 by American Society of Nephrology

REGULAR ARTICLES

Successful use of cuffed central venous hemodialysis catheters inserted percutaneously

RD Swartz, JM Messana, CJ Boyer, NM Lunde, WF Weitzel and TL Hartman
Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor 48109-0364.

Although endogenous fistulae and grafts are preferred for permanent hemodialysis access, central venous catheters are often required for varying intervals when creating permanent access is not feasible. The prospective experience with 118 catheters in over a 3.5-yr period is reported; 93 (79%) were placed by percutaneous techniques, and 25 (21%) were placed by operative techniques. Seventy seven catheters (65%) were placed in the subclavian vein, 36 (31%) were placed in the internal jugular vein (usually right side), and 5 (4%) were placed in the femoral vein. Early postplacement complications were infrequent. Catheter function at last local follow-up ranged from several days to nearly 2 yr, averaging approximately 3 mo, even though many patients returned to their referring centers with a functioning catheter after only a short follow-up. Actuarial survival for percutaneously placed catheters was approximately 60% at 6 mo and 30% at 12 mo. Catheter failure occurred in 36% of cases, equally divided between malfunction (thrombosis refractory to fibrinolysis, extrusion, kinking, or related event) and infection with septicemia requiring removal. Such failure was not more frequent after percutaneous placement than after operative placement. Failure due to mechanical malfunction, but not that due to infection, tended to be less frequent among catheters placed in the internal jugular vein than among catheters placed in the subclavian vein. Finally, infection with septicemia involved 22% of all catheters and occurred at an average cumulated rate of approximately one infection per patient-year. Coagulase-positive staphylococcus was the most common organism isolated.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
 CJASNHome page
M. Allon
Current Management of Vascular Access
Clin. J. Am. Soc. Nephrol., July 1, 2007; 2(4): 786 - 800.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
C. V. Poole, D. Carlton, L. Bimbo, and M. Allon
Treatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogen
Nephrol. Dial. Transplant., May 1, 2004; 19(5): 1237 - 1244.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
C. D. Miller, M. L. Robbin, J. Barker, and M. Allon
Comparison of Arteriovenous Grafts in the Thigh and Upper Extremities in Hemodialysis Patients
J. Am. Soc. Nephrol., November 1, 2003; 14(11): 2942 - 2947.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
D. W. Johnson, R. MacGinley, T. D. Kay, C. M. Hawley, S. B. Campbell, N. M. Isbel, and P. Hollett
A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters
Nephrol. Dial. Transplant., October 1, 2002; 17(10): 1802 - 1807.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
J. K. Wong, D. J. Sadler, M. McCarthy, J. C. Saliken, C. B. So, and R. R. Gray
Analysis of Early Failure of Tunneled Hemodialysis Catheters
Am. J. Roentgenol., August 1, 2002; 179(2): 357 - 363.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
A. Webb, M. Abdalla, and G. I. Russell
A protocol of urokinase infusion and warfarin for the management of the thrombosed haemodialysis catheter
Nephrol. Dial. Transplant., October 1, 2001; 16(10): 2075 - 2078.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
G. X. Zaleski, B. Funaki, J. Rosenblum, J. Theoharis, and J. Leef
Metallic Stents Deployed in Synthetic Arteriovenous Hemodialysis Grafts
Am. J. Roentgenol., June 1, 2001; 176(6): 1515 - 1519.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
B. Bastani, J. Minton, and S. Islam
Insufficient penetration of systemic vancomycin into the PermCath lumen
Nephrol. Dial. Transplant., July 1, 2000; 15(7): 1035 - 1037.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
S. O. Trerotola
Hemodialysis Catheter Placement and Management
Radiology, June 1, 2000; 215(3): 651 - 658.
[Abstract] [Full Text]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673